- WHO. World malaria report. WHO 2019; Available at
https://www.who.int/publications/i/item/9789241565721
- WHO. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for
Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. World Health Organization. 2012; Available at :
https://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf
- WHO. WHO Policy recommendation on intermittent preventive treatment during
infancy with sulphadoxine-pyrimethamine (IPTi-SP) for Plasmodium falciparum malaria control in Africa. World Health Organization. 2010; Available at :
https://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf?ua=1
- Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, et al. Efficacy
and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in
African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet (London, England). 2009;374(9700):1533-42. Available at:
https://pubmed.ncbi.nlm.nih.gov/19765816/
- Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, et al. The cost-effectiveness
of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PloS one.
2010;5(6):e10313. Available at:
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010313
- Esu EB, Oringanje C, Meremikwu MM. Intermittent preventive treatment for malaria in
infants. The Cochrane database of systematic reviews. 2019;12(12):Cd011525. Available at: https://pubmed.ncbi.nlm.nih.gov/31792925/
- WHO. GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016–2030. World Health
Organization. 2015. Available at : https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf
- Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, et al. Molecular
markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment
for malaria in Mozambican infants. The Journal of infectious diseases. 2008;197(12):1737-42. Available at:
https://academic.oup.com/jid/article/197/12/1737/867000
- Alexander N, Sutherland C, Roper C, Cissé B, Schellenberg D. Modelling the impact of
intermittent preventive treatment for malaria on selection pressure for drug resistance.
Malaria journal. 2007;6:9. Available at:
https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-6-9
- O’Meara WP, Smith DL, McKenzie FE. Potential impact of intermittent preventive
treatment (IPT) on spread of drug-resistant malaria. PLoS medicine. 2006;3(5):e141. Available at:
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030141
- Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, et al. Association of
transmission intensity and age with clinical manifestations and case fatality of severe
Plasmodium falciparum malaria. Jama. 2005;293(12):1461-70. Available at: https://pubmed.ncbi.nlm.nih.gov/15784869/
- Roca-Feltrer A, Carneiro I, Smith L, Schellenberg JR, Greenwood B, Schellenberg D. The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings. Malaria journal. 2010;9:282. Available at: https://pubmed.ncbi.nlm.nih.gov/20939931/
- Crawley J, Sismanidis C, Goodman T, Milligan P. Effect of intermittent preventive
treatment for malaria during infancy on serological responses to measles and other vaccines
used in the Expanded Programme on Immunization: results from five randomised controlled
trials. Lancet (London, England). 2012;380(9846):1001-10. Available at: https://pubmed.ncbi.nlm.nih.gov/22850358/
- Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-Resistant
Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015. Emerging infectious diseases. 2018;24(1):40-8. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749434/
- WHO. Reported estimates of MCV1 coverage. 2020. Available at :
https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragemcv1.html
- Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, et al. Cost-
effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bulletin of the World Health Organization. 2009;87(2):123-9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636201/
- UNICEF. Levels and Trends in Child Mortality. 2019; Available at